#USA #Brijit #BRIJ Medical #Premier Inc. #Marietta

BRIJ Medical Partners with Premier

BRIJ Medical, Inc. recently achieved a significant breakthrough in medical technology by securing a national group purchasing agreement with Premier, Inc. This agreement focuses on the company's non-invasive skin closure products, specifically the Brijjit® BP-100 and BP-75 Force Modulating Tissue Bridges. This milestone is set to transform how both healthcare providers and patients experience surgical recovery.

The Significance of the Award

Announced on December 15, 2024, the agreement allows Premier members to enjoy exclusive pricing and conditions tailored through Premier's negotiations. This collaboration is designed to promote patient safety while improving clinical outcomes and operational efficiencies. Tim Gleeson, CEO of BRIJ Medical, expressed his enthusiasm, stating, "This marks a significant step forward in our mission to enhance the surgical experience for both patients and surgeons."

Advancements in Healing Technology

The Brijjit Force Modulating Tissue Bridge offers several advantages over traditional techniques for skin closure. It addresses the issue of incision tension during wound closure and provides essential support while promoting better scar therapy. Most notably, this innovation eliminates the need for conventional sutures, glues, staples, or tapes, which can be both costly and time-consuming. In fact, the Brijjit technology allows for a closure time up to nine times faster than the placement of traditional sutures.

Research highlights the advantages of this technology, indicating it can reduce wound breakdown by an impressive 90% and minimize scar formation—decreasing scar area by 38%. The product's hypoallergenic adhesive also decreases the risk of skin allergies, making it a safer choice for patients.

Premier's Role in Healthcare Innovation

Premier, Inc. stands out as a leader in leveraging technology to enhance patient care. By serving approximately two-thirds of healthcare providers across the United States, Premier plays a vital role in the evolution of healthcare practices. Their commitment to integrating data analytics and innovative solutions empowers healthcare providers to enhance patient care outcomes while ensuring cost efficiency.

Clinical Evidence and Future Prospects

The flagship product from BRIJ Medical, the Brijjit® Force Modulating Tissue Bridge, boasts a wealth of scientific support. Clinical trials, including randomized studies, validate that it can dramatically decrease complications related to surgical procedures. With results indicating a 90% reduction in potential wound-related issues, BRIJ Medical's offerings represent a significant step forward for the industry.

By partnering with Premier, BRIJ Medical not only aims to enhance its market reach but also emphasizes its commitment to patient-centered care. As this collaboration unfolds, both healthcare professionals and patients can expect to benefit from innovative products that elevate the standards of surgical excellence.

For additional information on BRIJ Medical's offerings and to stay updated on future developments, visit BRIJmedical.com.